0001225208-12-007113.txt : 20120308
0001225208-12-007113.hdr.sgml : 20120308
20120308212739
ACCESSION NUMBER: 0001225208-12-007113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120306
FILED AS OF DATE: 20120308
DATE AS OF CHANGE: 20120308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caforio Giovanni
CENTRAL INDEX KEY: 0001533201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 12678812
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
doc4.xml
X0304
4
2012-03-06
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001533201
Caforio Giovanni
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
Pres., US Pharmaceuticals
Common Stock, $0.10 par value
2012-03-06
4
M
0
8811.0000
0.0000
A
55906.0180
D
Common Stock, $0.10 par value
2012-03-06
4
F
0
3204.0000
32.3300
D
52702.0180
D
Market Share Units
2012-03-06
4
A
0
11556.0000
0.0000
A
2016-03-06
Common Stock, $0.10 par value
11556.0000
11556.0000
D
Performance Shares
2012-03-06
4
A
0
3142.0000
0.0000
A
2012-03-31
Common Stock, $0.10 par value
3142.0000
8811.0000
D
Performance Shares
2012-03-06
4
M
0
8811.0000
0.0000
D
2012-03-31
Common Stock, $0.10 par value
8811.0000
0.0000
D
Performance Shares
2012-03-06
4
A
0
3353.0000
0.0000
A
2013-03-31
Common Stock, $0.10 par value
3353.0000
6430.0000
D
Performance Shares
2012-03-06
4
J
0
215.1952
0.0000
A
2013-03-31
Common Stock, $0.10 par value
215.1952
6645.1952
D
Performance Shares
2012-03-06
4
A
0
4138.0000
0.0000
A
2014-03-31
Common Stock, $0.10 par value
4138.0000
4138.0000
D
Performance Shares
2012-03-06
4
J
0
186.0000
0.0000
A
2014-03-31
Common Stock, $0.10 par value
186.0000
4324.0000
D
Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award.
Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award.
Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.
Represents performance shares earned under the 2009-2011 Long-Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
Represents performance shares earned under the 2010-2012 Long-Term Performance Award.
Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.
Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
Represents performance shares earned under the 2011-2013 Long-Term Performance Award.
Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.
Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.
/s/ Robert J. Wollin, attorney-in-fact for Giovanni Caforio
2012-03-08